Additionally, the consistency of our findings with the clinical reference range established by Finney et al. [18] adds further validity to the proposed threshold of 0.98 mg/L for elevated cystatin C, which was associated with 2.03-fold significantly higher odds of stroke morbidity in fully adjusted models (Supplementary Table S1). This evidence concerns the gene CST3 and stroke disorder.